These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 5605172)

  • 1. [Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis].
    Mazzei ES; Mazzei CM; Gotelli C
    Prensa Med Argent; 1967 Mar; 54(5):199-203. PubMed ID: 5605172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the effect of d-thyroxine in patients with increased serum lipid level].
    Steger H
    Wien Klin Wochenschr; 1968 Nov; 80(47):887-98. PubMed ID: 5717659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of hyperlipoproteinemias type II a and II b using dextro-thyroxine or D,L-alpha-methyl-thyroxine-ethylester].
    Schwartzkopff W
    Verh Dtsch Ges Inn Med; 1972; 78():1621-3. PubMed ID: 4353151
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results and prospects of the use of drugs acting on serum lipoproteins in atherosclerosis].
    Fasoli A
    Minerva Med; 1971 Sep; 62(72):3458-65. PubMed ID: 5097217
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of highly purified D-thyroxine ("Dyno") in hyperlipoproteinemias type II a and II b].
    von Löwis of Menar P; Klemens UH
    Verh Dtsch Ges Inn Med; 1972; 78():1623-5. PubMed ID: 4353152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypercholesteremia: a problem of daily practice].
    Stauffacher W; Pometta D
    Rev Med Suisse Romande; 1968 Nov; 88(11):737-52. PubMed ID: 5748404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arteriosclerosis obliterans of all four limbs. Hypercholesteremia and hyperlipemia. Ligation of the intestinal lymphatic trunk].
    Monserrat J; Ballesta F; Torre L
    Angiologia; 1971; 23(2):64-8. PubMed ID: 5575149
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Xiaoyu tablet on blood lipid and lipoproteins in hyperlipidemic rabbits with atherosclerosis.
    Xie ML; Gu ZL; Zhu LJ
    Chin Med J (Engl); 2005 Oct; 118(19):1651-3. PubMed ID: 16232351
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of the antidyslipemic action of a sulfomucopolysaccharide of pancreatic origin].
    Svetoni N; D'Alonzo D; Rechichi A
    Clin Ter; 1974 Oct; 71(1):33-48. PubMed ID: 4279159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities].
    Ciammaichella A; Solitro A; Arcuri P
    Clin Ter; 1975 Jul; 74(1):55-62. PubMed ID: 1222517
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 14. [Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
    Felt V; Strasek J; Bednár J
    Cas Lek Cesk; 1972 Sep; 111(40):929-31. PubMed ID: 4628030
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipemia: clinico-therapeutic experience with a heparinoid].
    De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M
    Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hyperlipoproteinemia in relation to recent classifications].
    Cloarec M
    Minerva Med; 1971 Sep; 62(72):3452-5. PubMed ID: 5097215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary studies on the effects of CoA administration on plasmatic lipids in man].
    Arrigo F; Vitale D; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):305-10. PubMed ID: 4786567
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A; Gennari C; Picchi M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes].
    Cucinotta D
    Minerva Med; 1972 Feb; 63(15):870-85. PubMed ID: 4259330
    [No Abstract]   [Full Text] [Related]  

  • 20. REDUCTION OF SERUM TRIGLYCERIDES IN PATIENTS TREATED WITH SODIUM D-THYROXINE.
    FELDMAN EB; CARTER AC
    Metabolism; 1963 Dec; 12():1132-40. PubMed ID: 14100284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.